Recovery of serum testosterone levels is an accurate predictor of survival from COVID-19 in male patients
Authors:
- Emily Toscano-GuerraETEmily Toscano-Guerra
- Mónica Martínez GalloMGMónica Martínez Gallo
- Iria Arrese-MuñozIAIria Arrese-Muñoz
- Anna GinéAGAnna Giné
- Pablo Gabriel-MedinaPGPablo Gabriel-Medina
- Mar Riveiro-BarcielaMRMar Riveiro-Barciela
- Fernando Martinez-ValleFMFernando Martinez-Valle
- Manuel Hernández-GonzálezMHManuel Hernández-González
- Ricardo Pujol BorrellRBRicardo Pujol Borrell
- Francisco Rodríguez-FriasFRFrancisco Rodríguez-Frias
Preprint
Abstract
Infection with SARS-CoV-2 portends a broad range of outcomes, from a majority of asymptomatic cases or mild clinical courses to a lethal disease. Robust correlates of severe COVID-19 include old age, male sex, poverty and co-morbidities such as obesity, diabetes or cardiovascular disease. A precise knowledge is still lacking of the molecular and biological mechanisms that may explain the association of severe disease with male sex. Here, we show that testosterone trajectories are highly accurate individual predictors (AUC of ROC = 0.928, p < 0.0001) of survival in male COVID-19 patients. Longitudinal determinations of blood levels of luteinizing hormone (LH) and androstenedione suggest an early modest inhibition of the central LH-androgen biosynthesis axis in a majority of patients, followed by either full recovery in survivors or a peripheral failure in lethal cases. Moreover, failure to reinstate physiological testosterone levels was associated with evidence of impaired T helper differentiation and decrease of non-classical monocytes. The strong association of recovery or failure to reinstate testosterone levels with survival or death from COVID-19 in male patients is suggestive of a significant role of testosterone status in the immune responses to COVID-19.Keywords
All Related Versions
- Published version: BMC Medicine, 20 (1), 1.
This publication has 68 references indexed in Scilit:
- Androgen Receptor Influences on Body Defense System via Modulation of Innate and Adaptive Immune SystemsThe American Journal of Pathology, 2012
- Enhanced immunological response by dendritic cells in male hypogonadismEuropean Journal of Clinical Investigation, 2012
- Standardizing immunophenotyping for the Human Immunology ProjectNature Reviews Immunology, 2012
- Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly MenNew England Journal of Medicine, 2010
- Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormonesNutrition & Metabolism, 2010
- Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responsesHuman Immunology, 2010
- Regeneration of dendritic cells in aged miceCellular & Molecular Immunology, 2010
- Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral InfectionJournal of Virology, 2005
- Do Men Have a Higher Case Fatality Rate of Severe Acute Respiratory Syndrome than Women Do?American Journal of Epidemiology, 2004
- Pulsatile iv Infusion of Recombinant Human LH in Leuprolide-Suppressed Men Unmasks Impoverished Leydig-Cell Secretory Responsiveness to Midphysiological LH Drive in the Aging MaleThe Journal of Clinical Endocrinology & Metabolism, 2001